Bevacizumab-IRDye800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bevacizumab-IRDye800CW, covering 2024-08-22 to 2024-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW [Phase 1]